泰永長征(002927.SZ):孫公司深圳智維雲取得營業執照
格隆匯12月16日丨泰永長征(002927.SZ)公佈,公司全資子公司深圳泰永電氣科技有限公司(“深圳泰永”)以自有資金投資設立全資子公司深圳市智維雲信息技術有限公司(“深圳智維雲”),深圳智維雲於近日取得了深圳市場監督管理局頒發的營業執照。
深圳智維的經營範圍:計算機軟硬件技術開發、銷售;國內貿易(法律、行政法規、國務院決定規定在登記前須經批准的項目除外);經營進出口業務(法律、行政法規、國務院決定禁止的項目除外,限制的項目須取得許可後方可經營)。
此次設立全資孫公司,系公司根據未來業務發展方向所實施的投資行為,有利於增強公司的軟件開發和系統集成能力,進一步增強公司的市場競爭力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.